Search API

ebola patient being treated in an isolation tent
Regeneron Pharmaceuticals triple antibody cocktail REGN-EB3 treats Ebola virus infections
depiction of sars with spikes
Moderna’s mRNA-1273 vaccine uses the messenger RNA delivery platform to encode for an S-2P immunogen
depiction of RNA
Moderna expands mRNA-1273 vaccine phase 3 study (COVE)
saliva test showing pink
RT-LAMP assay provides low-complexity, portable, and robust systems for real-time community screening
shark swimming in a tank
NIH funded RADx-tech emulates shark tank investing process
young European boys playing soccer
European children HSV1 infection rate exceeds 32 percent
tick that causes lyme disease
Valneva VLA15 vaccine was found immunogenic across all Lyme disease groups tested
100 $ bills in a lock box
Pfizer and BioNTech anticipate launching Phase 2b/3 safety and efficacy trial during the 2020 summer
lady justice
Mandatory coronavirus vaccinations could happen in the USA
sars virus and research
Valneva VLA2001 is a Vero cell-based highly purified inactivated vaccine candidate against the SARS-CoV-2 virus